Fighting Thyroid Cancer with Microgravity Research by Krüger, Marcus et al.
 International Journal of 
Molecular Sciences
Review
Fighting Thyroid Cancer with Microgravity Research
Marcus Krüger 1 , Daniela Melnik 1, Sascha Kopp 1, Christoph Buken 1,2, Jayashree Sahana 2,
Johann Bauer 3, Markus Wehland 1, Ruth Hemmersbach 4, Thomas J. Corydon 2,5,
Manfred Infanger 1 and Daniela Grimm 1,2,6,*
1 Clinic for Plastic, Aesthetic and Hand Surgery, Otto von Guericke University, 39120 Magdeburg, Germany;
marcus.krueger@med.ovgu.de (M.K.); daniela.melnik@med.ovgu.de (D.M.);
sascha.kopp@med.ovgu.de (S.K.); christoph.buken@gmx.de (C.B.); markus.wehland@med.ovgu.de (M.W.);
manfred.infanger@med.ovgu.de (M.I.)
2 Department of Biomedicine, Aarhus University, 8000 Aarhus C, Denmark; jaysaha@biomed.au.dk (J.S.);
corydon@biomed.au.dk (T.J.C.)
3 Max Planck Institute of Biochemistry, 82152 Martinsried, Germany; jbauer@biochem.mpg.de
4 Institute of Aerospace Medicine, Gravitational Biology, German Aerospace Center (DLR), Linder Höhe,
51147 Cologne, Germany; ruth.hemmersbach@dlr.de
5 Department of Ophthalmology, Aarhus University Hospital, 8200 Aarhus N, Denmark
6 Gravitational Biology and Translational Regenerative Medicine, Faculty of Medicine and Mechanical
Engineering, Otto von Guericke University, 39120 Magdeburg, Germany
* Correspondence: dgg@biomed.au.dk; Tel.: +45-8716-7693; Fax: +45-8612-8804
Received: 17 April 2019; Accepted: 23 May 2019; Published: 24 May 2019


Abstract: Microgravity in space or simulated by special ground-based devices provides an unusual
but unique environment to study and influence tumour cell processes. By investigating thyroid cancer
cells in microgravity for nearly 20 years, researchers got insights into tumour biology that had not been
possible under normal laboratory conditions: adherently growing cancer cells detach from their surface
and form three-dimensional structures. The cells included in these multicellular spheroids (MCS)
were not only altered but behave also differently to those grown in flat sheets in normal gravity, more
closely mimicking the conditions in the human body. Therefore, MCS became an invaluable model for
studying metastasis and developing new cancer treatment strategies via drug targeting. Microgravity
intervenes deeply in processes such as apoptosis and in structural changes involving the cytoskeleton
and the extracellular matrix, which influence cell growth. Most interestingly, follicular thyroid cancer
cells grown under microgravity conditions were shifted towards a less-malignant phenotype. Results
from microgravity research can be used to rethink conventional cancer research and may help to
pinpoint the cellular changes that cause cancer. This in turn could lead to novel therapies that will
enhance the quality of life for patients or potentially develop new preventive countermeasures.
Keywords: three-dimensional growth; spheroids; aggressiveness; metastasis; signal transduction;
cytokines; target
1. Introduction
For cancer biologists, microgravity-based research is still an unusual terrain. Microgravity (µg)
provides a physical condition that is not possible on Earth and interestingly, this condition may be ripe
for studying cancer [1,2]. The use of µg for cancer research was born at the end of the last millennium.
During the STS-90 (Space Transportation System) mission in 1998, primary cultures of human renal
cortical cells were cultured for six days aboard the space shuttle Columbia before they returned to
Earth for analysis. Hammond et al. [3] reported an alteration of 1632 of the 10,000 analyzed genes
relative to ground controls. This was the first experiment to show that reduced gravity can affect a
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wide range of genes of in vitro cultured cells. These findings led to the speculation that weightlessness
could also trigger cancer cells to change the expression of numerous proteins, which could be the basis
for the development of new targets for drugs.
Inside the human body, the cells normally grow surrounded by a structure-supporting extracellular
matrix together with a regulating biochemical microenvironment, which allows organs, as well as
tumours, to maintain their three-dimensional (3D) shapes. Under normal laboratory conditions,
adherent cells in vitro do not behave similarly to how they would react in vivo in the body: They grow
two-dimensionally (2D), spreading out into monolayers on Petri dishes or polystyrene surfaces, which
poses problems for scientists who study cancer by examining genetic changes affecting cell growth and
development [4]. During the last decades, scientists have developed several laboratory methods to
mimic the 3D growth of cancer cells.
Scaffold-based, spinner flask, liquid-overlay and hanging drop techniques were used to gain
multicellular spheroids (MCS). But from a certain size, these MCS showed necrosis inside [5]. Under µg
conditions, cells can arrange themselves scaffold-free into large MCS without any signs of necrosis [6].
MCS can help to develop new cancer treatment strategies, which might be later translated into in vivo
models. Today they represent a useful model for studying angiogenesis mechanisms and performing
pharmacological testing of chemotherapeutic agents such as tyrosine kinase inhibitors (lenvatinib,
sunitinib, sorafenib etc.), which are often used in metastatic cancer therapy [7]. In addition, they can be
applied in toxicological and radiation experiments [8,9].
Thyroid cancer is the most common form of endocrine malignancy. Over the past four decades,
incidence rates have increased worldwide [10]. According to the Global Cancer Statistics GLOBOCAN,
567,233 new cases were diagnosed in the world population, and 41,071 people died from thyroid cancer
in 2018 [11]. Poorly differentiated thyroid tumours are aggressive and metastasize early, resulting in
poor prognosis. Also, differentiated (papillary or follicular) thyroid cancer, that is usually well treatable,
could—in its recurrent form—become less-differentiated by diminishing its iodine uptake capability.
Thus, current treatment options for recurrent differentiated thyroid cancer are extremely limited and
patients show remarkably reduced survival. Scientists have searched intensely for new ways/methods
to identify targets for novel drugs—and some of them have considered to use experimentation in
altered gravity conditions (Figure 1) [12,13].
Int. J. Mol. Sci. 2019, 20, x 2 of 21 
 
gravity can affect a wide range of genes of in vitro cultured cells. These findings led to the speculation 
that weightlessness could also trigger cancer cells t  change the expression of numerous proteins, 
which could be the bas s for th  evelopment of new targets for drugs. 
Inside the human body, the cells normally grow surrounded by a structure-supporting 
extracellular matrix together with a regulating biochemical microenvironment, which allows organs, 
as well as tumours, to maintain their three-dimensional (3D) shapes. Under normal laboratory 
conditions, adherent cells in vitro do not behave similarly to how they would react in vivo in the 
body: They grow two-dimensionally (2D), spreading out into monolayers on Petri dishes or 
polystyrene surfaces, which poses problems for scientists who study cancer by examining genetic 
changes affecting cell growth and development [4]. During the last decades, scientists have 
developed several laboratory methods to mimic the 3D growth of cancer cells. 
Scaffold-based, spinner flask, liquid-overlay and hanging drop techniques were used to gain 
multicellular sph r ids (MCS). But from a certain size, these MCS showed necrosis i ide [5]. Under 
µg conditions, cells can arrange themselves scaffold-free into large MCS without any signs of necrosis 
[6]. MCS can help to develop new cancer treatment strategies, which might be later translated into in 
vivo models. Today they represent a useful model for studying angiogenesis mechanisms and 
performing pharmacological testing of chemotherapeutic agents such as tyrosine kinase inhibitors 
(lenvatinib, sunitinib, sorafenib etc.), which are often used in metastatic cancer therapy [7]. In 
addition, they can be applied in toxicological and radiation experiments [8,9]. 
Thyroid cancer is the most common form of endocrine malignancy. Over the past four decades, 
incidence rates have increased worldwi e [10]. According to the Global Cancer Statistics 
GLOBOCAN, 567,233 new cases were diagn sed in the world population, nd 41,071 peopl  died 
fr m thyroid cancer in 2018 [11]. Poorly differentiated thyroid tumours are aggressive and 
metastasize early, resulting in poor prognosis. Also, differentiated (papillary or follicular) thyroid 
cancer, that is usually well treatable, could – in its recurrent form – become less-differentiated by 
diminishing its iodine uptake capability. Thus, current treatment options for recurrent differentiated 
thyroid cancer are extremely limited and patients show remarkably reduced survival. Scientists have 
searched intensely for new ways/methods to identify targets for novel drugs – and some of them 
have considered to use experimentation in altered gravity conditions (Figure 1) [12,13]. 
 
Figure 1. Timeline: research on thyroid cancer in microgravity. White squares: studies in simulated 
µg; yellow squares: studies in real µg. PFC: parabolic flight campaign, TCC: thyroid cancer cells. 
Figure 1. Timeline: research on thyroid cancer in microgravity. White squares: studies in simulated µg;
yellow squares: studies in real µg. PFC: parabolic flight campaign, TCC: thyroid cancer cells.
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2. Ground-Based Techniques Allow Microgravity Research on Earth
Experiments in real µg (parabolic flights, sounding rocket flights, experiments on satellites, space
vehicles or space stations (Figure 2A)) are rare and expensive. For this reason, different ground-based
facilities have been developed to simulate µg on Earth [1]. Devices such as the fast-rotating clinostat
(FRC) [14], the rotating wall vessel (RWV) [15] or the random positioning machine (RPM) [16,17]
allow cost-efficient preparations of spaceflights as well as intensive research in stand-alone studies
(Figure 2B). The ground-based facilities have been shown to imitate µg effects for several (but for
not all) experimental conditions [18,19].
Int. J. Mol. Sci. 2019, 20, x 3 of 21 
 
2. Ground-Based Techniques Allow Microgravity Research on Earth 
Experiments in real µ g (parabolic flights, sounding rocket flights, experiments on satellites, 
space vehicles or space stations (Figure 2A)) are rare and expensive. For this reason, different ground-
based facilities have been developed to simulate µg on Earth [1]. Devices such as the fast-rotating 
clinostat (FRC) [14], the rotating wall vessel (RWV) [15] or the random positioning machine (RPM) 
[16,17] allow cost-efficient preparations of spaceflights as well as intensive research in stand-alone 
studies (Figure 2B). The ground-based facilities have been shown to imitate µg effects for several (but 
for not all) experimental conditions [18,19]. 
 
Figure 2. (A) Currently available and future (*) platforms for research in real µg. The highlighted 
boxes indicate altitude and duration ranges of the experiments; (B) Different ground-based facilities 
to simulate µg on Earth. Arrows indicate gravitational forces (Earth gravity) or movements to 
annulling gravity (“simulated µg”). Parts of the figure were drawn by using pictures from Servier 
Medical Art, licensed under a Creative Commons Attribution 3.0 Unported License 
(https://creativecommons.org/licenses/by/3.0/). 
3. The Behaviour of Normal Thyrocytes in Microgravity 
The structural feature of the thyroid tissue is the thyroid follicle. These follicles are formed by 
the cells that produce the thyroid hormones triiodothyronine (T3) and thyroxine (T4) and are called 
follicular epithelial cells or thyrocytes. In vivo, the thyrocytes are arranged in a single layer 
(epithelium) and surround the lumen of the follicles. In cross sections, the follicles of the healthy 
thyroid gland are round or oval. Microgravity changes the thyroid follicles [20]. The follicles reveal 
larger thyrocytes and show an elevation of cyclic adenosine monophosphate (cAMP), thyrotropin-
receptors and caveolin-1 [20,21]. Earlier in vitro and in vivo experiments demonstrated that 
thyrocytes respond to µg and hypergravity conditions [22–26]. Kossmehl et al. [23] showed that 
normal HTU-5 cells (obtained without transfection) [27] exposed to clinorotation revealed signs of 
apoptosis, as demonstrated by activation of caspase-3, increases in Fas and Bax and elevation of 85-
kDa apoptosis-related cleavage fragments resulting from enhanced poly(ADP-ribose) polymerase 
Figure 2. (A) Currently available and future (*) platforms for research in real µg. The highlighted
boxes indicate altitude and duration ranges of the experiments; (B) Different ground-based facilities to
simulate µg on Earth. Arrows indicate gravitational forces (Earth gravity) or movements to annulling
gravity (“simulated µg”). Parts of the figure were drawn by using pictures from Servier Medical Art,
licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/
licenses/by/3.0/).
3. The Behaviour of Normal Thyrocytes in icrogravity
The structural feature of the thyroid tissue is the thyroid follicle. These follicles are formed
by the cells that produce the thyroid hormones triiodothyronine (T3) and thyroxine (T4) and are
called follicular epithelial cells or thyrocytes. In vivo, the thyrocytes are arranged in a single layer
(epithelium) and surround the lumen of the follicles. In cross sections, the follicles of the healthy thyroid
gland are round or oval. Microgravity changes the thyroid follicles [20]. The follicles reveal larger
thyrocytes and show an elevation of cyclic adenosine monophosphate (cAMP), thyrotropin-receptors
and caveolin-1 [20,21]. Earlier in vitro and in vivo experiments demonstrated that thyrocytes respond to
µg and hypergravity conditions [22–26]. Kossmehl et al. [23] showed that normal HTU-5 cells (obtained
without transfection) [27] exposed to clinorotation revealed signs of apoptosis, as demonstrated
by activation of caspase-3, increases in Fas and Bax and elevation of 85-kDa apoptosis-related
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cleavage fragments resulting from enhanced poly(ADP-ribose) polymerase activity. Apoptosis was
found for various different cell types exposed to altered gravity conditions [28–31]. Results of
the TEXUS (German: ‘Technologische EXperimente Unter Schwerelosigkeit’)-44 sounding rocket
mission with FRTL-5 cells onboard showed that in real µg, normal thyroid cells do not respond
to thyroid-stimulating hormone (TSH) treatment and present an irregular shape with condensed
chromatin, a modification of the cell membrane with shedding of the TSH receptor in the supernatant,
as well as elevated sphingomyelin-synthase and Bax protein [22]. With the help of a rotary cell
culture system, differentiated thyroid neofollicles were located in close proximity after two weeks
of culture [24]. A time-dependent increase in human thyroglobulin was detected in the cell culture
supernatant. Exposure of thyrocytes in a rotary cell culture system under the presence of keratinocyte
growth factor (KGF) allowed the formation of artificial human thyroid organoids. They structurally
resembled natural thyroid tissue [24]. In addition, Nthy-ori 3-1 thyrocytes were able to form 3D
spheroids when exposed to an FRC or an RPM [25]. This cell line was originally obtained from normal
human primary thyrocytes transfected with a plasmid containing an origin-defective large T antigen
SV40 genome [32]. Although Nthy-ori 3-1 cells remain non-tumorigenic, they possess a few specific
features such as a strongly diminished thyroglobulin production and the presence of tri-tetraploid
clones. Nthy-ori 3-1 cells were exposed for 24 h and 72 h to an RPM. After a 24-h RPM-exposure,
they started to detach and to form 3D aggregates. The spheroids increased in number and size over time
(72 h), while adherent cells decreased [26]. Nthy-ori 3-1 cells secreted various cytokines in connection
with focal adhesion proteins and revealed positively or negatively interacting proteins, strengthening
the onset of MCS formation. The interleukins (IL)-6, IL-8 and TIMP-1 seemed to be involved in this
process [26]. Long-term RPM-exposure of Nthy-ori 3-1 cells demonstrated no signs of necrosis in the
centre of the spheroids [6]. The non-malignant thyroid cells did not express receptors for vascular
endothelial growth factor (VEGFRs) in a measurable amount [6] but they reacted with an up-regulation
of downstream signalling molecules, which hinted either to a delayed reaction to the simulated µg or
to further signalling molecules, which are involved in 3D-aggregate formation. The multipotent IL-6
could be a candidate that influences the cytoskeleton via β-actin [6]. IL-6 is known to be involved in
angiogenesis and metastasis not only in thyroid cancer but also in several other cancer types. Elevated
IL-6 concentrations could be explained by mechanically triggered activation of the specific surface
receptor CD44 [33]. It was suggested that the CD44-IL-6-connection plays a possible role in gravity
perception [6]. At least in pancreatic cancer cells, IL-6 stimulation activates the small GTPase cell
division cycle 42 (Cdc42) and thus promotes the formation of pre-migratory, actin-based filopodia [34].
In summary, normal thyrocytes revealed changes in the cytoskeleton, shredding of their
membranes, alterations in gene expression, protein synthesis and secretion and showed an increased
amount of apoptosis and a change in growth behaviour.
4. Research on Thyroid Cancer Cells in Microgravity
Research on thyroid cancer cells using µg conditions became a more and more interesting topic [1].
Nearly 20 years of µg research in this field provided a deeper insight into the growth behaviour and
signalling mechanisms of thyroid cancer (Figure 3). Since the first experiments in 2002, many studies
have been conducted both in real and simulated µg environments using different model cell lines
(ML-1, FTC-133 and UCLA RO-82W-1) and different research platforms (see also Figure 1).
• Ground-Based Studies
Growth of 3D-aggregates (Figures 3 and 4A) during random positioning was observed very
early [35] and it was found that apoptosis is involved in MCS formation [23,36]. Programmed cell
death of µg-exposed cells was also confirmed for other cell types [30,37]. In this setting, nuclear factor
kappa-light-chain-enhancer of activated B cells (NFκB) was identified as a key player [37]. Furthermore,
simulated µg affected gene expression patterns and the structure of the cytoskeleton already very early
after exposure to µg [38,39]. In addition to alterations of the F-actin morphology (Figure 4B,C), 30 min
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of clinorotation induced a disorganization of vimentin, cytokeratin and microtubules. However, these
changes were nearly reversed after 48 h [40]. This finding clearly supported the hypothesis that the
cytoskeleton may sense gravity in eukaryotic cells [41]. µg also increased the amount of extracellular
matrix (ECM) proteins in a time-dependent manner [40]. Based on the proteome data of different µg
experiments, Bauer et al. [42] postulated that the stability of the ECM has a great influence on MCS
formation under µg.
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were visible with increased F-actin deposits at the outer membranes of the MCS surface (green arrows);
(D,E) Immunofluorescence of vinculin (green) in UCLA RO-82W-1 cells. DAPI-stained nuclei are
shown in blue. Scale bars: 50 µm.
• Parabolic and Sounding Rocket Flights
Alternating phases of real µg (ca. 22 s), hypergravity and normal gravity during a parabolic flight
provide optimal conditions for investigating morphological and genetic alterations directly in the
transition from hypergravity toµg. A parabolic flight changed the morphology of the F-actin/cytokeratin
cytoskeleton of ML-1 cells as well as the expression status of genes involved in forming the cytoskeleton
and ECM [39]. Interestingly, the gene expression during the parabolic flight (and thus several changes
in gravity conditions) was often re ulated in the oppo ite direction co pared to the RPM or space [48].
Several sounding-rock t flights allowed further short-term experiments in real µg (about 6 min)
during the last years. The focus of these analyses was the very early mechanisms of cells exposed to real
µg aiming to detect the first steps that later lead to cell detachment and MCS formation. FTC-133 cells
expressing the LifeAct-GFP marker protein for the visualization of F-actin were flown on TEXUS-52
in 2015 and observed with live-cell imaging using the confocal FLUMIAS (Fluorescence-Microscopic
Analysis Systems for Space Application) microscope. They proved significant structural alterations
of the actin cytoskeleton as well as effects on the gene expression of genes involved in cytoskeleton
forming (EZR) and signalling (SEPT11) [49]. With the THYROID project on the TEXUS-53 mission in
2016, Kopp et al. [50] investigated the effects o short-term µg and hypergrav ty on the transcriptome
and proteome of FTC-133 cells. They identified a possible role of e idermal growth factor (EGF) and
vascular endothelial growth factor (VEGF) for spheroid formation in µg. In addition, they found that
µg is a stronger regulator of gene expression than hypergravity, which shortly occurs during the launch
of the rocket [51].
• Space Missions
The long-term xperiments in r al µg provided a deeper insight into the growth b haviour of
thyroid cancer cells in weightlessness excluding any additional shear forces as they might be induced
in ground-based facilities. This helped to evaluate whether µg was the trigger for the effects observed
in RPM experiments on Earth. After the SimBox/Shenzhou-8 mission in 2011, it became clear that
space-flown follicular thyroid cancer cells changed their proliferation, cell adhesion, growth behaviour,
and the post-flight results indicated that the cells shifted toward a less-aggressive phenotype [48].
Another interesting finding was that the confluence status of a cell culture could influence MCS
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formation. Preincubation of FTC-133 cells for five days before exposure to µg during the CellBox-1
mission completely inhibited the spheroid formation suggesting that the cell density together with high
amounts of ECM proteins and caveolin-1 are of great importance for 3D growth [52,53]. The CellBox-2
mission in 2017 allowed to investigate the effects of real µg on the transcriptome and proteome of
FTC-133 cells. The cells formed MCS in space and interestingly, these spheroids differed from MCS
generated on an RPM by an enhanced release of VEGF [54]. As VEGF has a key role in neoangiogenesis,
the enhanced production suggests a different angiogenic potential of thyroid cancer cells in space.
• Supporting Semantic Analyses
Genomic and proteomic analyses performed after exposing healthy and malignant thyroid cells to
devices simulating µg or to space or orbit flights unveiled a number of genes and proteins, which may
play a role when the cells adapt to µg [55–57]. Semantic analyses of these genes and proteins enabled
the identification of groups of interacting cellular entities and members of distinct pathways [58,59].
A group of gravisensitive genes was detected, which altered their transcription when exposed to µg.
They code for proteins, which are either secreted into the culture supernatant, inserted in the cell
membrane or located within the cytoplasm. Within the first 24 h of culturing the cells on an RPM, genes
coding for secreted proteins were up-regulated but those coding for membrane or cytoplasmic proteins
were down-regulated. After prolonged incubation, up-regulation of genes coding for membrane and
cytoplasm proteins was also observed. According to information retrievable from the literature, these
proteins form a network of interaction. They can either mutually influence their gene expression,
form complexes or regulate their activity. Interestingly, this interaction network not only includes the
products of gravisensitive genes but it also comprises proteins detected in culture supernatants by
multianalyte profiling technology upon the cells’ exposure to µg [6,25,43,52].
Another group of related proteins was found when a deep proteome analysis was evaluated.
This analysis was performed comparatively on thyroid FTC-133 cells, which were either incubated under
normal gravity conditions or on the RPM, where they were split into two populations, one continuing
to grow adherently, while the other one started to grow within a 3D aggregate. The evaluation showed
104 proteins of the integrin signalling pathway. In cells forming 3D aggregates during three days of
culture on the RPM, the levels of caveolin-1 and p130cas proteins were reduced but arf-GAP with
SH3 domain (ASAP1) production was enhanced. The results confirmed that caveolin-1 plays an
important role in spheroid formation [52] and challenged the speculation that the positions of the
proteins paxillin, vinculin and focal adhesion kinase may be changed by µg within the focal adhesion
complex in a way that favours cell detachment from the bottom of a culture flask. Preliminary hints
towards a µg-dependent change of intracellular vinculin distribution had already been observed during
a recent TEXUS flight [45,51]. Taking together, in vitro studies on thyroid cells exposed to microgravity
suggested that groups of proteins are affected by µg which interact over the membrane barrier and
provided first insights in the mechanisms of tissue cells leaving the site of growth to migrate to another
one as observed in metastasis [60].
4.1. Spheroids as a 3D Tumour Model
Both thyroid cancer cells and normal thyrocytes formed MCS [43,61], when they were cultivated
in (simulated) µg. Follicular thyroid cancer cells detached from the cell culture flask bottom and
assembled to compact 3D aggregates within a short time [35]. The tumour MCS were described to
mimic small metastases that are not as complex as the primary tumour but could resemble a part of their
organ of origin, reflecting a pathophysiological ‘inside-out’ situation (Figure 5) [62]. The ECM of MCS
differed in amount and composition from the corresponding monolayer cultures comprising a complex
3D network of cell-cell and cell-matrix interactions. These differences might facilitate the penetration
and action of drugs and affect the distribution and function of other physiological molecules such as
hormones and growth factors. Thus, the composition of MCS fundamentally determines the regulation
of cell growth, differentiation and apoptosis [62].
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An important task is to clarify the mechanisms for spheroid formation. Several factors are involved
in this process in addition to their role in metastasis and spreading of cancer cells in vivo (Tables 1
and 2). Some of these factors may serve as future targets in cancer therapy.
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Table 1. Selected articles addressing the mechanisms of spheroid formation of thyroid cancer cells
exposed to real or simulated µg.
Cell Line Condition Findings Ref.
FTC-133 Space ISS (5d)preincubation (12d)
t i lved in inhibition of 3D growth: caveolin-1,
VCAM-1 and activated protein kinase Cα recruited in caveolae [52]
FTC-133 Space ISS (5d)preincubation (12 )
Proteins involved in the inhibition of 3D growth: extracellular
matrix prot ins, phosphorylated profilin 1 [53]
FTC-133 Space (10d)Shenzhou 8
IL6, CXCL8, IL15, SPP1, VEGFA, VEGFD, FGF17, MMP2, MMP3,
TIMP1, PRKAA and PRKCA [48]
FTC-133 Space (10d)Shenzhou 8 CTGF and EGF [63]
FTC-133
RPM 3d, (2d)
preincubation (5d)
preincubation
i li , illin, focal adhesion kinase 1 and ade ine
diphosphate (ADP)-ribosylation factor 6 [45]
FTC-133,
Nthy-ori 3-1 RPM (14d)
VEGF, FLT-1. FLK-1, CD44, Copine 1, TGM2, IL-6, IL-8, IL-17,
OPN, neutrophil gelatinase-associ t d lipoc lin (NGAL, LCN2) [6]
ML-1,
RO82-W-1 RPM (3d), FRC (7d)
ML-1 cells: elevated release of IL-6 and monocyte
chemoattractant protein (MCP-1) [64]
Table 2. Genes involved in spheroid formation.
Pathway/Function G nes
Cell adhesion VCAM1, CD44, CDH1
Angiogenesis VEGFD, VEGFA, FLK1
Apopt sis TGFB1
Caveolae CAV1
Extracellular matrix SPP1, MMP2, MMP3, TIMP1, FN1, COL1A1
Inflammation IL6, CXCL8, IL17
NFκB signalling NFKB1
Protein kinases PRKAA, PRKCA
Cytoskeleton ACTB, TUBB, FN1
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An interesting finding was that caveolin-1 is a key factor for the inhibition of spheroid formation
when confluent monolayers are exposed to µg [52]. The results of a pathway analysis using the data of
these articles (Table 1) are given in Figure 6.
Int. J. Mol. Sci. 2019, 20, x 9 of 21 
 
 
Figure 6. Semantic analysis of factors involved in spheroid formation: (A) Protein-protein regulation 
of follicular thyroid cancer cells exposed to µ g; (B) Direct protein interactions; (C) Gene interaction of 
various differentially regulated genes of thyroid cancer cells exposed to µ g conditions. Connecting 
lines indicate binding, arrows show directed interaction; green lines with ‘+’ signs point to an 
enhancing effect, red lines with perpendicular bars indicate inhibition. Networks were built up using 
Pathway Studio v.11 (Elsevier, Amsterdam, The Netherlands). 
An interesting finding was that caveolin-1 is a key factor for the inhibition of spheroid formation 
when confluent monolayers are exposed to µg [52]. The results of a pathway analysis using the data 
of these articles (Table 1) are given in Figure 6. 
Ten of numerous studies on the behaviour of thyroid cells revealed proteins and genes coding 
for proteins that appear to be key proteins in spheroid formation. The studies were performed at very 
different time points on different populations of thyroid cells, culturing the cells either on an RPM, a 
clinostat or in space. The 31 proteins recognized as being important in MCS formation were, besides 
copine-1, all members of the networks of interaction according to the literature evaluated by the 
Elsevier Pathway Studio. 
As demonstrated in Figure 6, various factors are involved in the formation of spheroids. The 
next step would be to study them in more detail. A first step was done by targeting E-cadherin in 
MCF-7 breast cancer cells [65]. The proto-oncogene tyrosine-protein kinase c-Src was detected in 
MCF-7 MCS. Anti-E-cadherin antibodies had enhanced the amount of MCS. The agent PP2, blocking 
the E-cadherin reducer SRC, prevented MCS formation completely [65]. 
Figures 6A,B show protein interaction networks. Looking at the mutual regulation of the 
proteins, it can be seen that 29 proteins form a network influencing the activity of each other (see 
Figure 6. Semantic analysi of actors invol i f r ation: (A) Protein-protein regulation
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Studio v.11 (Elsevier, Amsterdam, The Netherlands).
Ten of umerous studies on the behaviour of th roid cells revealed proteins and genes coding
for proteins that appear to be key proteins in spheroid formation. The studies were performed at
very different time points on different populations of thyroid cells, culturing the cells either on an
RPM, a clinostat or in space. The 31 proteins recognized as being important in MCS formation were,
besides copine-1, all members of the networks of interaction according to the literature evaluated by
the Elsevier Pathway Studio.
As demonstrated in Figure 6, various factors are involved in the formation of spheroids. The next
step would be to study them in more detail. A first step was done by targeting E-cadherin in MCF-7
breast cancer cells [65]. The proto-oncogene tyrosine-protein kinase c-Src was detected in MCF-7 MCS.
Anti-E-cadherin antibodies had enhanced the amount of MCS. The agent PP2, blocking the E-cadherin
reducer SRC, prevented MCS formation completely [65].
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Figure 6A,B show protein interaction networks. Looking at the mutual regulation of the proteins,
it can be seen that 29 proteins form a network influencing the activity of each other (see Figure 6A).
In most cases, the influence is stimulating (green arrows). Only a few red lines with little perpendicular
bars at their ends indicate inhibition. PTK2, the focal adhesion kinase, seems to play a central role
in this system, as most of the arrows point to its icon. As the icon of VEGF-A is a starting point
for a considerable number of green arrows, one may conclude that VEGF-A is a strong initiator of
spheroid formation. Interestingly, 21 of the proteins investigated bind physically to each other forming
complexes (connecting lines) or triggering the partner’s activity (green arrows) (Figure 6B). In two
cases, TIMP1-MMP2 and CAV1-KDR inhibition were indicated (red lines with the perpendicular bar at
the side of inhibited protein). In this system of binding, fibronectin seems to play a central role.
Figure 6C shows that 27 of the proteins recognized as being important in spheroid formation
influence each other’s mRNA expression. As shown by the high number of arrows the mutual gene
expression regulation is very intensive. Again, most proteins favoured the expression of the partner
protein’s mRNA (green arrows). Still a considerable number inhibits (red line with perpendicular
bar at the end). In this system VEGFA, KDR, IL6 and CXCL8 are indicated as dominant target genes
as many arrows point to their icons. Noteworthy is that many green arrows start at the SPP1 icon.
This suggests that osteopontin is a major trigger of spheroid formation.
Figure 7 provides a comparative overview of the current cell (culture) models used for cancer
research. It visualizes possibilities and limits of the different model types including µg-grown tumour
spheroids. The µg-based method is able to provide a large number of MCS in a short time and is suitable
for long-term experiments (no necrotic cores) as well as for cocultures. MCS were used for a variety of
experimental studies using radiotherapy, chemotherapy, radioimmunotherapy, cell- and antibody-based
immunotherapy, hyperthermia, gene therapy and photodynamic treatment [66]. Further, they serve as
an invaluable experimental and theoretical model for basic research on proliferation, viability, energy
metabolism, nutrient metabolism, invasion, cell-cell interactions and extracellular matrix composition
helping to better estimate in vivo antitumor treatment modalities [66]. But although thyroid cancer
cells grow in 3D structures in µg, MCS do not possess blood vessels that can provide oxygen and
nutrients. Therefore, the MCS size remains limited.
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4.2. Growth of Thyroid Cancer Cells in Microgravity–A Temporary Mimicry of Metastasis?
When a (progressive) tumour spreads from its primary site to another part of the organism this
process is called metastasis. Metastatic cancer is characterized by the same type of cancer cells as
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the primary cancer. The tumour starts to extend and invades into the structures and tissues in its
surrounding area. The first description of a thyroid metastasis was made by Rudolf Virchow in 1871,
who found metastatic thyroid cells inside a testis [67]. Thyroid cancer mostly spreads to the lymph
nodes, lungs, bone and occasionally to the brain. Follicular thyroid cancer tends to spread to distant
sites via the blood vessels (hematogenously), as opposed to papillary thyroid cancer, which metastasizes
through the lymphatic system (lymphogenously), usually to local lymph nodes. As angioinvasion is
associated with the risk of recurrence, the differentiation of lymphatic and angioinvasion is of high
importance [68]. Survival and growth of metastases at the new sites needs angiogenesis: The tumour
forms a new blood supply by building new blood vessels. Metastasis is responsible for more than
90% of all the cancer-associated deaths. Approximately 30% of patients suffering from thyroid cancer
develop metastases [69] and the incidence of distant metastasis after thyroidectomy remains between
7% and 23% [70]. In rare cases metastasis is associated with malignant ascites (especially described
for medullary thyroid cancer [71]). Metastatic ascites containing multicellular spheroids can promote
chemo-resistance and recurrence [72]. Model mechanisms relating to how single cells aggregate to form
MCS once detached are important. MCS have been used in developmental biology and experimental
cancer research for many years [73]. They are used as in vitro models of tumour microregions and as
early avascular stage of tumour growth [62,66,74].
Progression and aggression of cancer are known to be closely connected to mechanical stress [75]
resulting in alterations of cytoskeletal structures, cellular shape, proliferation, differentiation, cell
adhesion, survival/death and migration [76,77]. The loss of gravity can also be a stressor for adherently
growing cells that may be induced by tensegrity (tensional integrity) after gravitational unloading [78,79].
Interestingly, there are many parallels between the detachment of single cells from the primary tumour
during metastasis and the detachment of adherently growing cells in µg (Table 3). Whereas metastasis
is forced, among other factors, by the external pressure from the growing tumour [76], a possible
physical trigger for cell detachment in µg is the lapse of gravity.
Research using MCS focused on mechanisms involved in proliferation, invasion and metastasis.
µg conditions have been shown to induce 3D growth of benign and malignant cells [72]. A great
advantage of µg-engineered MCS is that they do not develop a necrotic centre when cultured for several
weeks [6,80]. Interestingly, results hint to a re-differentiation of follicular thyroid cancer cells in space to
a less-aggressive phenotype (see chapter 4.4.) [48]. These findings are supported by recent data obtained
with melanoma cells types exposed to µg. BL6-10 cells did not form multicellular spheroids but revealed
comparable results, as clinostat-simulated µg reduced proliferation, adhesion and invasiveness in vitro
and decreased tumour lung metastasis in vivo. Clinorotation also down-regulated metastasis-related
integrin α6β4, MMP9 and Met72 molecules. Further, it significantly reduced the formation of focal
adhesions and activation of the focal adhesion kinase (FAK), Rho family proteins (RhoA, Rac1 and
Cdc42) and mTORC1 kinase but activated AMPK and ULK1 kinases [81]. Clinostat-exposure of the
cells inhibited focal adhesions and induced inhibition of FAK and RhoA signalling and the mTORC1
pathway, which resulted in the activation of the AMPK pathway and thus reducing melanoma cell
proliferation and metastasis. µg further changed the cytoskeleton and nuclear positioning, leading
to enhanced cell apoptosis by suppressing the FAK/RhoA-regulated mTORC1/NFκB and ERK1/2
pathways [82]. Similar data were found by Grosse et al. [61] investigating follicular thyroid cancer
(FTC-133) cells. Especially invasive follicular thyroid cancer is known to show an extensive vascular
invasion [68]. FTC-133 cells grown on the RPM showed higher levels of NFκB p65 protein and apoptosis
than controls grown under normal gravity (1g), a result also found earlier in endothelial cells [31].
IL6, CXCL8, CD44 and SPP1 were significantly up-regulated in adherent cells but not in MCS, while
ERK1/2, CAV2, TLN1 and CTGF were significantly down-regulated in adherent cells. Simultaneously,
the expression of ERK2, IL6, CAV2, TLN1 and CTGF was reduced in 3D MCS compared to 1g samples.
The signalling elements IL-6, IL-8, OPN, TLN1 and CTGF were involved together with NF-κB p65 in the
RPM-dependent thyroid carcinoma cell MCS formation. Similar findings were reported with glioma
cells exposed to µg [83]. Simulated µg induced apoptosis of U251 cells. The FAK/RhoA/Rock and
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FAK/Nek2 signalling events were attenuated by simulated µg to destabilize the actin cytoskeleton and
centrosome disjunction, which caused G2/M arrest and inhibition of cell viability and migration [83].
The FAK/RhoA/Rock and FAK/Nek2 pathways are affected by simulated µg and might serve as future
targets. In addition, an earlier study showed that simulated µg reduced the metastatic potential of
human lung adenocarcinoma cells by diminishing the expression of antigen MKI67 and MMP2, thereby
inhibiting cell proliferation, migration and invasion [84]. In addition, MMP2 was reduced in the
thyroid cancer space samples [48], supporting the results of Chang et al. [84] that simulated µg exerts
an antiproliferative effect on lung cancer cells.
Table 3. Comparison between exposure to µg and metastasis.
Microgravity (Detachment) Metastases (Detachment)
Physical Trigger Lapse of gravity (tensegrity, mechanical stress) Pressure from growing tumour
Cytoskeleton
Formation of filopodia and lamellipodia [49] Formation of filopodia andlamellipodia [85]
PFN↑ [6], phosphorylated profilin-1 prevented
MCS formation [43] Profilin 1↓ [86]
Cell Adhesion Blockage of E-cadherin leads to enhanced spheroidformation of MCF-7 breast cancer cells [65] E-cadherin↓ [87]
ECM MMP9↑ [43]; OPN↑ [61] MMP9↑ [88]; OPN↑ [89]
Cytokines IL-6↑, IL-8↑ [6] IL-6↑ [87]; IL-8 enhancesmetastatic potential [90]
Growth Factors VEGF-A↑ [48]
VEGF↑ facilitates metastasis
through the VEGF-VEGFR1
signalling pathway [91]
Others CD44↑ [61] CD44↑ [92]
↓ down-regulation; ↑ up-regulation; AD: adherent cells; MCS: multicellular spheroids.
4.3. Reduced Aggressiveness of Thyroid Cancer Cells after Long-Term Exposure to Real Microgravity
When thyroid cancer cells had been examined after cultivation on an RPM at various time-points
results suggested that µg initiated a re-differentiation of dedifferentiated FTC-133 cells after long-term
RPM-exposure (Figure 8) [6]. The exact mechanisms behind this transformation are still unknown.
After 7 and 14 days, expression of angiogenic factors like VEGF-A was significantly down-regulated,
whereas the expression of apoptotic factors was increased. This suggested that exposure to simulated
µg enabled selective programmed cell death, which identified the cells more differentiated compared to
those grown under normal conditions [6]. Similar results were obtained from the SimBox/Shenzhou-8
mission when FTC-133 cells were cultured on an unmanned spacecraft for two weeks. Space-flown cells
were shifted towards a less-malignant phenotype by down-regulation of VEGFA and up-regulation
of VEGFD and IL15 [48]. IL6, CXCL8, SPP1, PRKAA and PRKCA mRNAs were all reduced both in
adherent cells and MCS grown in space. As VEGF-A was found increased and VEGF-D serum levels
were reported to be reduced in patients suffering from high-stage thyroid cancer [93,94], the authors
concluded that µg possibly triggers some antitumor pathways involving IL-15 [48]. Consistent
with these results a down-regulation of VEGFA was also found in the space-flown cells after the
CellBox-2 mission, whereas the mRNA level of VEGFA stayed rather constant during a respective RPM
experiment [54]. This VEGF discrepancy was often observed when results of simulated µg experiments
were compared with data from real µg studies. Here it should be noted that VEGF gene expression is
also up-regulated by the cells as a result of mechanical stress. It may be that fluid shear stress caused
by random positioning [19,95,96] contributed to higher VEGFA mRNA levels of the RPM samples.
In contrast to the space studies, the short-term exposure to real µg during a parabolic flight suggested
an increased malignancy of the FTC-133 cells [48].
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4.4. Drug Targeting
Using proteome analysis, Pietsch et al. [97] were able to detect the expression of 37 proteins
previously not found in thyroid cells. Of special interest is the plastin-2, which plays a crucial role
in the development of thyroid tumours, as well as the interferon-induced 17 kDa protein precursor,
which is coded by the ISG15 gene [42]. This protein ay be conjugated to target proteins by the E1
and E2 enzymes. Of the more than 150 yet known target proteins [98], we found 71 in the thyroid
cells investigated [42]. During incubation on the RP the protein’s accu ulation decreased [45,56].
However, when RNA expression was analyzed, after thyroid cells had been cultured for 10 days in
space or on the RP , a considerable up-regulation of the gene expression was observed [42,48,63].
ISG15 plays a role in antiviral i unity [99]. Recently a drug (Q63) was described, which exerted
antiviral activity by down-regulation of ISG15 [100]. Even in cancer research ISG15 has attracted
attention. It was recognized to be a prognostic arker in hu an breast cancer [101]. Studies on CF7
cells suggested that the protein plays a role in stabilization of MCS generated on an RPM [65]. How the
latter findings apply to thyroid cancer remains to be determined.
Bauer et al. [59] detected 69 proteins, which are significantly accumulated in thyroid cancer
cells in the transition from 2D cell growth in normal gravity to spheroid growth in µg. These factors
seem to be part of an overarching mechanism and therefore they are very interesting candidates
for targeted tumour therapy. Reduction or inhibition of metastasis by knock-down or knock-out of
one of these factors would decisively improve cancer therapy as well as patient survival. After the
exploratory phase researchers have now begun with the functional analysis of previously detected
genes. Using phar acological targeting or silencing of individual genes, they are able to inhibit
selected signalling path ays. CF-7 breast cancer cells hich ere incubated ith the FκB
inhibitor dexa ethasone sho ed dose-dependent inhibition of spheroid for ation [37]. The artificial
glucocorticoid dexa ethasone functionally inhibits FκB and FκB-dependent gene expression.
Based on these results in µg research, it was proved that NFκB plays a crucial role in spheroid formation
in breast cancer tumours. Further studies with the Src inhibitor PP2 and an anti-E-cadherin antibody
also showed an influence on the spheroid formation of MCF-7 cells [65]. While the presence of PP2
completely inhibited spheroids, the E-cadherin antibody stimulated the formation of 3D structures.
Both drugs had no effect on cell viability and all cells survived after pharmacological intervention.
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Similar attempts are planned for thyroid cancer research in the near future. The pharmacological
substances that appear to be suitable are listed in Table 4.
Table 4. Potential drugs targeting the proteins that were found to be influenced by µg.
Drug Target Ref.
PP2 (4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)
pyrazolo[3,4-d]pyrimidine) Proto-oncogene tyrosine-protein kinase Src [102]
Daidzein Caveolin-1 [103]
Camptothecin Ubiquitin-like protein ISG15 [104]
SP600125 Mitogen-activated protein kinase 8 [105]
mNOX-E36 C-C motif chemokine 2 [106]
Dexamethasone, BAY 11-7082 NFκB p65 [107]
GSK2256098, MPAP Focal adhesion kinase 1 [108]
MT189 Paxillin [109]
Baicalein Ezrin [110]
Curcumin HMOX-1 [111]
DX52-1 Radixin [112]
TM5441 Plasminogen activator inhibitor 1 [113]
UK370106 Stromelysin, (MMP3) [114]
Oseltamivir Sialidase [115]
5. Summary and Perspectives
Microgravity alters growth, cell adhesion, migration, proliferation, the cytoskeleton, extracellular
matrix and focal adhesion of human cells in vitro. A large number of differentially regulated genes
and altered protein synthesis and secretion are detectable in benign and malignant cells exposed to
real or simulated µg. The model system ‘Multicellular Spheroid’ is suitable to mimic metastasis of
solid tumours and can be used for drug testing in pharmacology or as a coculture model to study
processes like metastasis or angiogenesis. The investigation of the underlying mechanisms of spheroid
formation also delivers valuable information about the in vivo cancer progression and metastasis.
Research in the fields of space medicine and gravitational biology makes it possible to find new
proteins in organ tissues and changes in protein synthesis and secretion. Altered gravity conditions
provide a new technology which is helpful to detect changes in proteins which may represent new
targets for drug development in cancer. A large number of proteins which may serve as promising
targets and available drugs are listed in Table 4. In order to address cancer growth and regulation,
further µg studies should be performed. We recently investigated changes of SOX transcription
factors on FTC-133 follicular thyroid cancer cells exposed to the RPM and determined the mRNA
expression of SOX9 and SOX11 in adherently growing and MCS cells [47]. The SOX family is involved
in the progression and metastasis of cancer cells. Its expression in thyroid cancer is not clarified until
today and requires further investigation. Studies focusing on the role of SOX family members and
in particular the SoxF group in radioactive iodine-refractory differentiated thyroid cancer cells are of
high interest. Recent results in the field of cancer research in µg taught us that focal adhesions play
an important role in the inhibition of proliferation and metastasis in melanoma cells [81]. Therefore,
intensive research in thyroid cancer investigating focal adhesions should be performed in µg by
applying live-cell imaging with the FLUMIAS microscope [49] onboard the ISS or on sounding rockets.
Microgravity research is just one part of cancer research but might enable a significant step toward
better treatments. Some years ago, with the help of simulated µg various proteins were detected in
thyroid tissue for the first time [97]. Some of them are targeted today. In addition, the compounds
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given in Table 4 are currently under investigation. The results may truly provide hope for thyroid
cancer patients.
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Abbreviations
2D Two-dimensional
3D Three-dimensional
ACTB β-Actin
AD Adherent cells
AMPK 5′Adenosine monophosphate-activated protein kinase
CAV1/2 Caveolin-1, -2,
CD44 Cluster of differentiation 44
CTGF Connective tissue growth factor
CXCL C-X-C motif
ECM Extracellular matrix
EGF Epidermal growth factor
ERK1/2 Extracellular signal-regulated kinase 1,2
FGF17 Fibroblast growth factor 17
FLK1 Fetal liver kinase 1
FLUMIAS Fluorescence-microscopic analysis systems for space application
FLT1 Fms-related tyrosine kinase 1
FN1 Fibronectin
FRC Fast-rotating clinostat
IL Interleukin
KDR Kinase insert domain receptor
MCS Multicellular spheroid
MMP Matrix metalloproteinase
µg Microgravity
Nek2 Serine/threonine-protein kinase Nek2
NFκB Nuclear factor κ-light-chain-enhancer of activated B cells
OPN Osteopontin
PRKAA Protein kinase, AMP-activated, α catalytic subunit
PRKCA Protein kinase Cα
RhoA Ras homolog gene family, member A
RPM Random positioning machine
RWV Rotating wall vessel
SOX Sex determining region Y-related high-mobility group box proteins
TGF-β Transforming growth factor β
TIMP1 Tissue inhibitor of metalloproteinases 1
TLN1 Talin 1
TSH Thyroid-stimulating hormone
TUBB β-tubulin
VEGF Vascular endothelial growth factor
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